% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@INBOOK{Srivastava:613874,
author = {Srivastava, Sukrit and Chatziefthymiou, Spyros D. and
Kolbe, Michael},
title = {{V}accines {T}argeting {N}umerous {C}oronavirus {A}ntigens,
{E}nsuring {B}roader {G}lobal {P}opulation {C}overage:
{M}ulti-epitope and {M}ulti-patch {V}accines; 2nd ed. 2022},
volume = {2410},
address = {New York, NY},
publisher = {Springer US},
reportid = {PUBDB-2024-05653},
isbn = {978-1-0716-1884-4},
series = {Methods in Molecular Biology},
pages = {149 - 175},
year = {2022},
comment = {[Ebook] Vaccine Design : Methods and Protocols, Volume 1.
Vaccines for Human Diseases / Thomas, Sunil 2nd ed. 2022,
New York, NY : Springer US, 2022,},
booktitle = {[Ebook] Vaccine Design : Methods and
Protocols, Volume 1. Vaccines for Human
Diseases / Thomas, Sunil 2nd ed. 2022,
New York, NY : Springer US, 2022,},
abstract = {Challenges for Vaccinologists in the First Half of the
Twenty First Century -- Principles in Immunology for the
Design and Development of Vaccines -- Revisiting the
Principles of Designing a Vaccine -- Status of COVID-19
Pandemic before the Administration of Vaccine -- mRNA
Vaccines to Protect against Diseases -- Artificial
Intelligence in Vaccine and Drug Design -- Vaccines
Targeting Numerous Coronavirus Antigens, Ensuring Broader
Global Population Coverage: Multi-Epitope and Multi-Patch
Vaccines.-Use of Micro-computed Tomography to Visualize and
Quantify COVID-19 Vaccine Efficiency in Free-breathing
Hamsters -- Design of Replication-Competent VSV- and
Ervebo-vectored Vaccines against SARS-CoV-2 -- CRISPR
Engineering of Bacteriophage T4 to Design Vaccines against
SARS-CoV-2 and Emerging Pathogens -- Techniques for
Developing and Assessing Immune Responses Induced by
Synthetic DNA Vaccines for Emerging Infectious Diseases --
Towards Determining the Epitopes of the Structural proteins
of SARS-CoV-2 -- Development, production and
characterization of hepatitis B subviral envelope particles
as a third-generation vaccine -- Generation of CpG-Recoded
Zika Virus Vaccine Candidates -- Salmonella Uptake into
Gut-Associated Lymphoid Tissues: Implications for Targeted
Mucosal Vaccine Design and Delivery -- Development of Human
Recombinant Leptospirosis Vaccines -- Induction of T-cell
Responses by Vaccination of a Streptococcus pneumoniae Whole
Cell Vaccine -- Development of a Bacterial Nanoparticle
Vaccine against Escherichia coli -- Construction of Novel
Live Genetically Modified BCG Vaccine Candidates using
Recombineering Tools -- An Update on Tuberculosis Vaccines
-- Structure-Based Design of Diagnostics and Vaccines for
Lyme Disease -- Development of a SONIX vaccine to protect
against ehrlichiosis -- Development of the Anti-Leishmanial
Vaccine -- In Silico Design of Recombinant Chimera T Cell
Peptide Epitope Vaccines for Visceral Leishmaniasis --
Pre-clinical Assessment of the Immunogenicity of
Experimental Leishmania Vaccines -- Production of Oral
Vaccines Based on Retrovirus Virus-like Particles
Pseudotyped with Protozoan-Surface Proteins -- A Fast-Track
Phenotypic Characterization of Plasmodium falciparum Vaccine
Antigens through Lyse-Reseal Erythrocytes Mediated Delivery
(LyRED) of RNA Interference for Targeted Translational
Repression -- Plasmodium falciparum Antigen Expression in
Leishmania Parasite: A Way Forward for Live Attenuated
Vaccine Development -- Molecular Characterization of a
Vector-based Candidate Antigen using the 3'–RACE and
Genome Walking Methods and In Silico Analysis of the
Correspondent Protein for Vaccine Design and Development --
In vitro culture of Plasmodium falciparum for the Production
of Mature Gametocytes for Performing Standard Membrane
Feeding Assay and Infection of Anopheles spp. -- Plasmodium
berghei Infection in BALB/c Mice Model as an Animal Model
for Malaria Disease Research -- Standard membrane feeding
assay for malaria transmission studies -- Generation of
Tumor Targeted Dendritic Cell Vaccines with Improved
Immunogenic and Migratory Phenotype -- Monocytes as a
Cellular Vaccine Platform to Induce Anti-Tumor Immunity --
Beyond Sequencing: Prioritizing and Delivering Neoantigens
for Cancer Vaccines -- Proteomics for Development of Food
Allergy Vaccines -- Estimating Vaccine Potency using
Antibody-based Competition Assays.},
cin = {FS-PETRA-D / CSSB-HZI-MK},
ddc = {570},
cid = {I:(DE-H253)FS-PETRA-D-20210408 /
I:(DE-H253)CSSB-HZI-MK-20210520},
pnm = {633 - Life Sciences – Building Blocks of Life: Structure
and Function (POF4-633)},
pid = {G:(DE-HGF)POF4-633},
experiment = {EXP:(DE-MLZ)NOSPEC-20140101},
typ = {PUB:(DE-HGF)7},
pubmed = {pmid:34914046},
doi = {10.1007/978-1-0716-1884-4_7},
url = {https://bib-pubdb1.desy.de/record/613874},
}